Hypertension Diagnostics, Inc.
Cardiovascular diagnostics firm reports 10% increase in revenue
Published in Cardiovascular Business Week, October 11th, 2005
Revenue for fiscal 2005 totaled $1,182,005 compared to $1,074,515 in the prior year ended June 30, 2004, which represents a 10% increase from the prior year. The company incurred a net loss of $1,455,228 for fiscal 2005 or $0.05 per share compared with a net loss of $1,839,949 for fiscal 2004 or $0.08 per share.
Included in the net loss of $1,455,228 for fiscal 2005 are total non-cash charges expenses associated with stock compensation, depreciation, stock options of $337,976. Included in the net loss of $1,839,949 for fiscal 2004 are total...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cardiovascular Business Week
More Articles from Cardiovascular Business Week
- CV Therapeutics, Inc.
Molecular cardiology company reports option grants - FoxHollow Technologies
Plaque excision device company and Merck enter drug development agreement - Xigen S.A.
Swiss biotech company closes series A financing round with US$21 million - Aachen University of Technology
Study evaluated accuracy of Emory Cardiac Tool Box - Abbott
U.S. FDA grants approval for device to treat patients at risk of stroke - Actelion Ltd
Long-term safety profile of bosentan drug in treating PAH confirmed in study - More from this issue of Cardiovascular Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
